Eocene (EOCN) vs China SXT Pharmaceuticals (SXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
China SXT Pharmaceuticals is the larger company by market cap ($3.7 million vs $3.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | EOCN | SXTC |
|---|---|---|
| Share price | $3.46 | $2.83 |
| Market cap | $3.69M | $3.74M |
| 1-day change | +2.91% | +126.40% |
| EPS (TTM) | $-15.21 | $-1,680.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.88 | $83,760.00 |
| 52-week low | $3.12 | $1.18 |
| Distance from 52-week high | -73.15% | -100.00% |
| Average volume | 60.46K | 1.48M |
| Shares outstanding | 1.07M | 1.32M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
EOCN vs SXTC FAQ
Which is bigger, Eocene or China SXT Pharmaceuticals?
China SXT Pharmaceuticals (SXTC) is larger, with a market capitalization of $3.74M compared with $3.69M for Eocene (EOCN).
Are Eocene and China SXT Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.